An aPPARent functional consequence in skeletal muscle physiology via peroxisome proliferator-activated receptors

Phua, Wendy Wen Ting, Wong, Melissa Xin Yu, Liao, Zehuan, Tan, Nguan Soon·2018·International Journal of Molecular Sciences

Cites (219)

Items 201–220 of 220

  1. Pharmacological targeting of exercise adaptations in skeletal muscle: Benefits and pitfalls
    Martin Weihrauch, Christoph Handschin · 2017 · Biochemical Pharmacology
  2. Association between the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene and Strength Athlete Status
    Agnieszka Maciejewska, Marek Sawczuk, Paweł Cięszczyk, Aleksandra Zarębska, Stanisław Sawczyn · 2013 · PLoS ONE
  3. PPAR alpha, more than PPAR delta, Mediates the Hepatic and Skeletal Muscle Alterations Induced by the PPAR Agonist GW0742
    Brenda Faiola, James Greg Falls, Richard A. Peterson, Nancy R. Bordelon, Thomas A. Brodie, Connie A. Cummings, Elizabeth H. Romach, Richard Thomas Miller · 2008 · Toxicological Sciences
  4. Mechanisms Regulating GLUT4 Transcription in Skeletal Muscle Cells Are Highly Conserved across Vertebrates
    Rubén Marín‐Juez, Mònica Dı́az, Jordi Morata, Josep V. Planas · 2013 · PLoS ONE
  5. Effect of Aging on the Expression of Peroxisome Proliferator-Activated Receptor γ and the Possible Relation to Insulin Resistance
    Ping Ye, Zhang Xiu-jin, Zhaojun Wang, Cheng Zhang · 2006 · Gerontology
  6. PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference
    Yuan Z. Feng, Nataša Nikolić, Siril Skaret Bakke, Mark V. Boekschoten, Sander Kersten, Eili Tranheim Kase, Arild C. Rustan, G. Hege Thoresen · 2013 · Archives of Physiology and Biochemistry
  7. Adipophilin protein expression in muscle – a possible protective role against insulin resistance
    Janneke de Wilde, Egbert Smit, Frank J. M. Snepvangers, Nicole J. W. de Wit, Ronny Mohren, Martijn F.M. Hulshof, Edwin C.M. Mariman · 2009 · FEBS Journal
  8. Thiazolidinediones (PPARγ ligands) increase IRS-1, UCP-2 and C/EBPα expression, but not transdifferentiation, in L6 muscle cells
    Ann Hammarstedt, Ulf Smith · 2003 · Diabetologia
  9. Peroxisome proliferator-activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice
    Cécile Giordano, Anne‐Sophie Rousseau, Nicole Wagner, Céline Gaudel, Joseph Murdaca, Chantal Jehl-Piétri, Brigitte Sibille, Paul André Grimaldi, Pascal Lopez · 2009 · Pflügers Archiv - European Journal of Physiology
  10. Free Fatty Acid Metabolism in Human Skeletal Muscle Is Regulated by PPARγ and RXR Agonists
    Theodore P. Ciaraldi, BONG‐SOO CHA, KYONG‐SOO PARK, Leslie Carter, Sunder Raj D. Mudaliar, Robert R. Henry · 2002 · Annals of the New York Academy of Sciences
  11. Not all the number of skeletal muscle fibers is determined prenatally
    Mingsen Li, Xingyu Zhou, Yaosheng Chen, Yaping Nie, Huaxing Huang, Hu Chen, Delin Mo · 2015 · BMC Developmental Biology
  12. Inactivation of PPARβ/δ adversely affects satellite cells and reduces postnatal myogenesis
    Preeti Chandrashekar, Ravikumar Manickam, Xiaojia Ge, Sabeera Bonala, Craig McFarlane, Mridula Sharma, Walter Wahli, Ravi Kambadur · 2015 · American Journal of Physiology-Endocrinology and Metabolism
  13. Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndrome
    Hiroaki Ueno, Yukie Saitoh, Masanari Mizuta, Tomomi Shiiya, Kenji Noma, Shinichi Mashiba, Shiho Kojima, Masamitsu Nakazato · 2011 · Obesity Research & Clinical Practice
  14. Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516
    Bharat R. Lagu, Arthur F. Kluge, Matthew M. Goddeeris, Effie Tozzo, Ross A. Fredenburg, Shekar Chelur, Ramesh S. Senaiar, Mahaboobi Jaleel, D. Ravi Krishna Babu, Nirbhay Kumar Tiwari et al. · 2017 · Bioorganic & Medicinal Chemistry Letters
  15. Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing
    Bharat R. Lagu, Arthur F. Kluge, Ross A. Fredenburg, Effie Tozzo, Ramesh S. Senaiar, Mahaboobi Jaleel, Sunil K. Panigrahi, Nirbhay Kumar Tiwari, Narasimha Rao Krishnamurthy, Taisuke Takahashi et al. · 2017 · Bioorganic & Medicinal Chemistry Letters
  16. Metabolic and molecular changes associated with the increased skeletal muscle insulin action 24–48 h after exercise in young and old humans
    Francis B. Stephens, Kostas Tsintzas · 2018 · Biochemical Society Transactions
  17. Different response of senescent female Sprague–Dawley rats to gemfibrozil and rosiglitazone administration
    Elena Sanguino, Núria Roglans, Marta Alegret, Rosa M. Sánchez, Manuel Vázquez‐Carrera, Juan Carlos Laguna · 2005 · Experimental Gerontology
  18. Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure
    Ronald B. Myers, Jun Yoshioka · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  19. Fibrates
    Peter H. Jones · 2009 · Elsevier eBooks
  20. Untitled work
    Randle · 1998 · 10.1002/(sici)1099-0895(199812)14:4